BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2022 2:41:53 AM | Browse: 355 | Download: 709
 |
Received |
|
2021-12-28 04:17 |
|
Peer-Review Started |
|
2021-12-28 04:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-02-08 09:56 |
|
Revised |
|
2022-03-05 08:21 |
|
Second Decision |
|
2022-04-12 01:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-04-21 18:16 |
|
Articles in Press |
|
2022-04-21 18:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-05-18 08:15 |
|
Publish the Manuscript Online |
|
2022-05-20 02:41 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Minireviews |
| Article Title |
SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Adekunle Sanyaolu, Aleksandra Marinkovic, Stephanie Prakash, Nafees Haider, Martina Williams, Chuku Okorie, Olanrewaju Badaru and Stella Smith |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Adekunle Sanyaolu, PhD, Academic Research, Director, Director, Department of Public Health, Federal Ministry of Health, New Federal Secretariat Complex, Phase III, Ahmadu Bello Way, Central Business District, Abuja 0000, Nigeria. sanyakunle@hotmail.com |
| Key Words |
SARS-CoV-2; COVID-19; Omicron; B.1.1.529; Variant of concern; Emerging variants |
| Core Tip |
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, Omicron (B.1.1.529), was first reported to World Health Organization from South Africa on November 24, 2021. Omicron has been labeled a variant of concern because of genetic changes that increase transmissibility and decrease the effectiveness of health measures, vaccines, and therapeutics. This variant has 32 mutations in the spike protein, which is problematic because vaccinations designed to prevent SARS-CoV-2 infections target spike proteins. Despite some evidence that vaccination alone may not be enough, non-pharmaceutical practices such as continued use of face masks, proper hygiene precautions, and social distancing, are required to successfully combat this variant. |
| Publish Date |
2022-05-20 02:41 |
| Citation |
Sanyaolu A, Marinkovic A, Prakash S, Haider N, Williams M, Okorie C, Badaru O, Smith S. SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape. World J Virol 2022; 11(3): 137-143 |
| URL |
https://www.wjgnet.com/2220-3249/full/v11/i3/137.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v11.i3.137 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
